Hematopoietic Stem Cell TransplantationTransplantation, AutologousPeripheral Blood Stem Cell TransplantationStem Cell TransplantationTransplantation, HomologousTransplantation ConditioningHematopoietic Stem Cell MobilizationMelphalanCombined Modality TherapyHematologic NeoplasmsMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsHematopoietic Stem CellsGraft vs Host DiseaseAntigens, CD34Granulocyte Colony-Stimulating FactorTreatment OutcomeLeukapheresisStem CellsCyclophosphamideMyeloablative AgonistsBone Marrow TransplantationBlood Component RemovalLymphoma, Non-HodgkinRemission InductionBusulfanEtoposideGraft SurvivalRecurrenceSalvage TherapyThiotepaCarmustineDisease-Free SurvivalAntineoplastic Agents, AlkylatingHodgkin DiseaseCytarabineVincristineAmyloidosisRetrospective StudiesSurvival RateTissue DonorsHematopoiesisTransplantation ChimeraIfosfamideWhole-Body IrradiationSurvival AnalysisHistocompatibility TestingCord Blood Stem Cell TransplantationDoxorubicinTime FactorsBone Marrow PurgingImmunosuppressive AgentsCytophagocytosisFollow-Up StudiesDexamethasoneNeoplasmsLeukemiaHistocompatibilityPrednisoneAntineoplastic AgentsLeukemia, Myeloid, AcuteLymphomaInfectionPrognosisTransplantationCarboplatinMesenchymal Stem Cell TransplantationCytomegalovirus InfectionsStem Cell NicheAdult Stem CellsProspective StudiesVidarabineCell DifferentiationLiver TransplantationFatal OutcomeEmbryonic Stem CellsAnemia, AplasticPlatelet CountBone MarrowTransplantation, IsogeneicLymphoma, T-CellMyelodysplastic SyndromesGraft vs Leukemia EffectFeasibility StudiesHepatic Veno-Occlusive DiseaseHLA AntigensKidney TransplantationPOEMS SyndromeImmunocompromised HostFlow CytometryRecombinant ProteinsBone Marrow CellsCell TransplantationBlood Cell CountNeoplasm, ResidualHematologic DiseasesOpportunistic InfectionsCells, CulturedAntibodies, Monoclonal, Murine-DerivedPrecursor Cell Lymphoblastic Leukemia-Lymphoma